News &amp; Updates

Tantangan dalam hal vaksinasi, baik pada anak maupun dewasa, menjadi lebih nyata di masa pandemi COVID-19 ini. Solusi konkret untuk mengatasinya menjadi bagian dari pembahasan materi oleh Prof. Dr. dr. Hartono Gunardi, Sp.A(K), Prof. Dr. dr. Siti Setiati, Sp.PD-KGer, dan dr. Siti Nadia Tarmizi, M.Epid pada Vaccine Summit kolaborasi Sanofi Indonesia dengan KEMENKES RI, PERALMUNI dan IIF yang mengakhiri rangkaian webinar untuk Pekan Imunisasi Dunia pada 24 April 2022.

Enhancing Confidence in Vaccination and Uptake in Covid-19 Pandemic Era

Update On Influenza and Covid-19 Co-Infection

Di masa pandemi ini, mendiagnosis influenza menjadi lebih sulit karena gejala yang tumpang tindih dengan COVID-19. Walaupun manifestasi gejala influenza pada umumnya ringan, namun komplikasi seperti pneumonia berat juga dapat terjadi. Bahkan, koinfeksi virus influenza dan SARS-CoV-2 cukup banyak dilaporkan. Hal ini dibahas lebih lanjut pada webinar kolaborasi Sanofi Indonesia dengan KEMENKES RI, PERALMUNI dan IIF dalam rangka Pekan Imunisasi Dunia, pada 20 April 2022 dengan pembicara Prof. Dr. dr. Cissy B Kartasasmita, Sp.A(K), M.Sc, Ph.D dan Prof. Dr. dr. Iris Rengganis, Sp.PD-KAI, FINASIM.

Update On Influenza and Covid-19 Co-Infection

Decitabine as good as, but safer than, chemo in AML

01 Jul 2022 by

Extended treatment with decitabine is as good as, but safer than, standard induction chemotherapy (IC) in older patients with acute myeloid leukaemia (AML), according to a phase III study presented at EHA 2022.

Decitabine as good as, but safer than, chemo in AML

Ibrutinib-bendamustine-rituximab combo promising for older patients with mantle-cell lymphoma

A treatment combination comprising the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib plus bendamustine and rituximab, followed by rituximab maintenance therapy, improved progression-free survival (PFS) in older patients with untreated mantle-cell lymphoma, according to results of the SHINE* trial presented at ASCO 2022.

Ibrutinib-bendamustine-rituximab combo promising for older patients with mantle-cell lymphoma

30 Jun 2022

Poor glycaemic control tied to COVID-19 progression

High concentrations of glycated haemoglobin (HbA1c) at hospital admission appears to increase the risk of COVID-19 progression to severe disease, a recent study has found.

Poor glycaemic control tied to COVID-19 progression

30 Jun 2022

Persistent ALT elevation triples risk of future T2D among overweight, obese children

Children with overweight or obesity risk developing future type 2 diabetes (T2D) by threefold in the presence of persistent elevations in alanine aminotransferases (ALT), according to a study presented at the 54th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN 2022).

Persistent ALT elevation triples risk of future T2D among overweight, obese children

30 Jun 2022

Medication-assisted therapy tied to arrhythmia in patients with opioid use disorder

In patients diagnosed with opioid use disorders, those who received medication-assisted therapy (MAT) prescriptions have a higher risk of cardiac arrhythmia than those who did not, reports a study.

Medication-assisted therapy tied to arrhythmia in patients with opioid use disorder

Methotrexate proven safe, effective as first-line immunomodulator in paediatric CD

Use of methotrexate (MTX) appears safe and effective as first-line immunomodulator for maintenance therapy in children with Crohn’s disease (CD), suggests a study presented at the 54th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN 2022).

Methotrexate proven safe, effective as first-line immunomodulator in paediatric CD

Optimism helps prevent cardiovascular disease, death

Being optimistic appears to reduce the risk of all-cause mortality and of cardiovascular disease (CVD), claims a recent study.

Optimism helps prevent cardiovascular disease, death

30 Jun 2022

Thyroidectomy for PTMC: less complications, more recurrence with partial vs total removal

In a systematic review and meta-analysis of studies on primary surgical treatment outcomes for individuals with papillary thyroid microcarcinoma (PTMC; ≤1.0 cm at greatest diameter), hemithyroidectomy (HT) was associated with lower risks of postoperative complications but a higher incidence of overall recurrence compared with total thyroidectomy (TT).

Thyroidectomy for PTMC: less complications, more recurrence with partial vs total removal